# A Pilot Study to Evaluate the Efficacy of Ariva® Silver Wintergreen, a Smoking Aversive Lozenge

> **NCT01336816** · PHASE1 · COMPLETED · sponsor: **Star Scientific, Inc** · enrollment: 43 (actual)

## Conditions studied

- Tobacco Use Disorder
- Smoking

## Interventions

- **OTHER:** Ariva Silver Wintergreen
- **OTHER:** Placebo Wintergreen

## Key facts

- **NCT ID:** NCT01336816
- **Lead sponsor:** Star Scientific, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2014-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01336816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01336816, "A Pilot Study to Evaluate the Efficacy of Ariva® Silver Wintergreen, a Smoking Aversive Lozenge". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01336816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*